Trial Profile
A Study to Evaluate the Efficacy and Safety of Pregabalin in Patients with Uncontrolled Neuropathic Pain
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Dec 2015
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms UNIDOL
- 24 Dec 2015 New trial record